DCM
GILD icon

Decatur Capital Management’s Gilead Sciences GILD Stock Holding History

Decatur Capital Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-78,233
Closed -$4.94M – 62
2020
Q3 		$4.94M Buy
78,233
+14,940
+24% +$1.04M 0.97% 44
2020
Q2 		$4.87M Buy
63,293
+12,601
+25% +$966K 1.29% 29
2020
Q1 		$3.79M Sell
50,692
-12,949
-20% -$895K 1.27% 32
2019
Q4 		$4.13M Sell
63,641
-37,949
-37% -$2.47M 0.95% 48
2019
Q3 		$6.44M Sell
101,590
-39,425
-28% -$2.58M 1.59% 20
2019
Q2 		$9.53M Sell
141,015
-3,251
-2% -$214K 1.79% 17
2019
Q1 		$9.38M Buy
144,266
+38,866
+37% +$2.58M 1.81% 16
2018
Q4 		$6.59M Buy
+105,400
New +$7.37M 1.48% 30
2014
Q4 		– Sell
-122,500
Closed -$13M – 100
2014
Q3 		$13M Buy
122,500
+24,275
+25% +$2.38M 2.19% 17
2014
Q2 		$8.14M Sell
98,225
-49,400
-33% -$3.85M 1.54% 25
2014
Q1 		$10.5M Buy
147,625
+50,175
+51% +$3.94M 1.99% 11
2013
Q4 		$7.32M Buy
+97,450
New +$6.79M 1.41% 26

Other funds holding GILD

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Decatur Capital Management's GILD Position: Q4 2020 in Review

Decatur Capital Management sold out of Gilead Sciences (GILD) in Q4 2020, closing a stake of 78,233 shares — an estimated $4.94M sold.

Decatur Capital Management first reported a position in GILD in Q4 2013 and held it in 12 quarters. The position peaked at $13M in Q3 2014. 1,563 funds tracked by Wall St. Rank hold GILD as of Q4 2020.

  • Decatur Capital Management reported no remaining Gilead Sciences position as of Q4 2020 after selling out during the quarter.
  • Decatur Capital Management sold 78,233 Gilead Sciences shares in Q4 2020, an estimated $4.94M.
  • Decatur Capital Management first reported a position in Gilead Sciences in Q4 2013 and held it in 12 quarters.
  • Decatur Capital Management's Gilead Sciences position peaked at $13M in Q3 2014.
  • 1,563 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2020.

Based on Decatur Capital Management's 13F filing for Q4 2020, filed 28 Jan 2021.